Notice of Intent to Sole Source to TopRX
Closed Special Notice Posted
- Agency
-
Indian Health Service
Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Oklahoma City, Oklahoma 73114, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Health and Human Services Indian Health Service has issued a Notice of Intent to Sole Source to TopRX for the procurement of Lentocilin, a critical medication used to treat syphilis. The Oklahoma City Area Indian Health Center intends to award a non-competitive contract valued at $211,200 for 14,080 doses at $15 per dose to address nationwide shortages of Bicillin L-A (penicillin G benzathine injectable suspension). The procurement is being conducted under FAR Part 6.302-1, which allows for sole source contracting when only one responsible source can provide the required supplies. TopRX is currently the only FDA-authorized supplier capable of temporarily importing Lentocilin while the primary product remains on production hold. The contract covers the 2025-2026 fiscal period and falls under NAICS code 325412 for Pharmaceutical Preparation Manufacturing.
The primary purpose of this sole source procurement is to ensure an adequate supply of medication to treat congenital syphilis patients and support mission-critical deployments combating syphilis outbreaks across Indian Country in the United States. This notice is not a request for competitive proposals, and no solicitation will be available for competitive quotes. However, potential respondents have until August 15, 2025, at 4:00 PM CST to submit written responses demonstrating clear and convincing evidence that competition would be advantageous to the government. The government reserves the right to use any non-proprietary technical information in future solicitations but is under no obligation to acknowledge receipt of responses or provide feedback. Any contractor wishing to challenge this sole source determination must provide compelling evidence of their capability to supply the required medication, though the government maintains full discretion in its final procurement decision.
Notice text
INTENT TO SOLE SOURCE TO TOPRX FOR LENTOCILIN
The Oklahoma City Area Indian Health Center intends to award a non-competitive, sole source contract to proposed contractor TopRX. authority cited FAR Part 5.406(a) - Only one source is capable of providing the required Lentocilin, to address the shortages of Bicillin L-A (penicillin G benzathine injectable suspension) in the United States.
This product is the only available treatment option for congenital Syphilis patients and those at high risk of contracting it. An ample supply is needed throughout the Indian Health Services to ensure prompt treatment and to support ongoing mission critical deployments aimed at combating Syphilis outbreaks across Indian Country in the United States.
This notice of intent to award a sole source contract is not a request for competitive proposals. There will be no solicitation available for competitive quotes. Any response to this notice must show clear and convincing evidence, that competition would be advantageous to the Government. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. Provide response to: Forrest.Ward@ihs.gov. Last day to provide affirmation written response is August 15, 2025 at 4:00pm CST.
A determination by the Government not to compete the proposed procurement base upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for determining whether to conduct a competitive procurement in the future. Any solicitation resulting from the analysis of information obtained will be announced to the public in Federal Business Opportunities. However, responses to this notice will not be considered adequate responses to a solicitation. No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation (s).
Files
| File | Type | Posted |
|---|---|---|
| INTENT TO SOLE SOURCE TOPRX.pdf | ||
| J-and-A-Lentocilin 2025 (1).pdf |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity